Dr. Go is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
30 Prospect Avenue
Department of Internal Medicine
Hackensack, NJ 07601Phone+1 551-996-3500Fax+1 551-996-3298
Education & Training
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Pulmonary Disease and Critical Care Medicine, 2010 - 2013
Maimonides Medical CenterResidency, Internal Medicine, 2007 - 2009
Atlantic Health System/Overlook Medical CenterInternship, Internal Medicine, 2006 - 2007
Angeles University FoundationClass of 2004
Certifications & Licensure
MA State Medical License 2009 - 2026
NC State Medical License 2009 - 2025
NJ State Medical License 2015 - 2025
NY State Medical License 2010 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Publications & Presentations
PubMed
- 6 citationsMethylprednisolone and 60 Days in Hospital Survival in Coronavirus Disease 2019 PneumoniaRonaldo C. Go, Roshan Shah, Themba Nyirenda, Yukiko Oe, Khurram Sarfraz
Critical Care Explorations. 2021-07-01 - 2 citationsRacial/ethnic disparities on inflammation and response to methylprednisolone in severe COVID-19 pneumonia.Ronaldo C Go, Themba Nyirenda, Maryam Bojarian, Davood K Hosseini, Kevin Kim
BMC Infectious Diseases. 2022-03-14 - 200 citationsTocilizumab among patients with COVID-19 in the intensive care unit: a multicentre observational study.Noa Biran, Andrew Ip, Jaeil Ahn, Ronaldo C. Go, Shuqi Wang
The Lancet. Rheumatology. 2020-10-01
Journal Articles
- Tocilizumab in Hospitalized Patients with Severe Covid-19 PneumoniaIvan O Rosas, Ronaldo C Go, Ivor S Douglas, Larry Tsai, Atul Malhotra, The New England Journal of Medicine
- Tocilizumab Among Patients with COVID-19 in the Intensive Care Unit: A Multicentre Observational StudyNoa Biran, Andrew Ip, Ronaldo Collo Go, The Lancet Rheumatology
Authored Content
- Hydroxychloroquine and tocilizumab therapy in COVID-19 patients-An observational studyAugust 2020
- Tocilizumab Among Patients with COVID-19 in the Intensive Care Unit: A Multicentre Observational StudyAugust 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
